This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Monday's Small-Cap Winners & Losers

SpectraLink's (SLNK) shares were surging after the company was upgraded by JPMorgan to overweight from neutral. Shares were rising 13.4% to $9.31 on heavy volume.

A.P. Pharma (APPA) was higher on word it was granted an exclusive license to RHEI Pharmaceuticals to develop and sell APF530 in China and Taiwan. APF530 is currently in phase III trials in the U.S. for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. Shares of A.P. Pharma were up 15% to $1.23.

Magnetek (MAG - Get Report) got a lift from an upgrade by B. Riley & Co., which raised its rating on the company to buy from neutral. Magnetek was recently gaining 10.7% to $3.83.

Streicher Mobile Fueling (FUEL - Get Report), a provider of petroleum-distribution services, slumped following its estimate that it will post a loss of $4.8 million for the year ended June 30. Last year, the company lost $1.46 million. Streicher also said it expects to report its fourth-quarter and year-end results to the Securities and Exchange Commission within the next 14 days. The stock was lower by 17.1% to $1.79.

Alphatec Holdings (ATEC - Get Report) skidded 16.4% after First Albany downgraded the stock. The firm took its rating to neutral from buy, and Alphatec was dropping 94 cents to $4.78.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs